Key statistics dashboard for Profusa, Inc. Common Stock (PFSA). Valuation multiples (P/E, P/B, EV/EBITDA), profitability margins, financial-health ratios, per-share metrics and stock-level data in one consolidated view — the snapshot quantitative analysts and value investors check first.
Profusa, Inc., a digital health technology company, develops bioengineered sensors for body to detect and continuously transmit clinical-grade data for personal and medical use in the United States. It offers the Lumee Oxygen Platform to monitor compromised tissue for peripheral artery disease, chronic wounds, and reconstructive surgery. The company researches and develops the Lumee Glucose Platform which is designed to monitor glucose levels in interstitial fluid.
Stock Data
| Price | $1.78 |
| Market Cap | $2M |
| Enterprise Value | $15.4M |
| Exchange | NASDAQ |
| Country | US |
Valuation Multiples
| P/E Ratio | -0.01 |
| Price / Book | -0.00 |
| P/S | 0.00 |
| EV/EBITDA | -0.44 |
| EV/Sales | 0.00 |
| EV/FCF | -0.73 |
| P/FCF | -0.10 |
| Earnings Yield | -39211.79% |
| FCF Yield | -1004.37% |
| Dividend Yield | 0.00% |
Profitability
| Gross Margin | 0.00% |
| EBIT Margin | 0.00% |
| EBITDA Margin | 0.00% |
| Operating Margin | 0.00% |
| Net Margin | 0.00% |
| Return on Equity | 148.25% |
| Return on Assets | -4123.80% |
| Return on Invested Capital | 242.59% |
| Return on Capital Employed | 117.35% |
Financial Health
| Current Ratio | 0.03 |
| Quick Ratio | 0.03 |
| Cash Ratio | 0.03 |
| Debt / Equity | -0.52 |
| Debt / Assets | 1343.95% |
| Net Debt / EBITDA | -0.38 |
| Interest Coverage | -6.03 |
| Piotroski F-Score | 2 |
| Altman Z-Score | -77.01 |
Per-Share Data
| Revenue per share | 0.00 |
| Book Value per share | -470.33 |
| Cash per share | 12.47 |
| FCF per share | -364.80 |
| Tangible Book Value per share | -470.33 |
| Dividend per share | 0.00 |
Related companies: ACXP · ADIL · APRE · BCDA · BFRI · CHEK · GBS
Explore sector: Healthcare · Medical - Devices
More sections of PFSA: Overview · Financials · Valuation · Estimates · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks